All Stories

  1. Endogenous Two-Photon Fluorescence Imaging Elucidates Metabolic Changes Related to Enhanced Glycolysis and Glutamine Consumption in Precancerous Epithelial Tissues
  2. Human Viral Oncogenesis: A Cancer Hallmarks Analysis
  3. Are Selective Estrogen Receptor Modulators (SERMs) a Therapeutic Option for HPV-Associated Cervical Lesions and Cancers?
  4. The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines
  5. Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis
  6. The papillomavirus E7 proteins
  7. Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines
  8. Biochemical and Functional Interactions of Human Papillomavirus Proteins with Polycomb Group Proteins
  9. The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor Species
  10. The Human Papillomavirus Type 8 E6 Protein Interferes with NOTCH Activation during Keratinocyte Differentiation
  11. Human papillomavirus type 16 E7 oncoprotein engages but does not abrogate the mitotic spindle assembly checkpoint
  12. Cancer associated human papillomaviruses
  13. Viral Perturbations of Host Networks Reflect Disease Etiology
  14. Modulation of Autophagy-Like Processes by Tumor Viruses
  15. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer
  16. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses
  17. Elucidating metabolic, subcellular, and tissue-level changes induced by HPV-related oncoproteins
  18. Automated Biochemical, Morphological, and Organizational Assessment of Precancerous Changes from Endogenous Two-Photon Fluorescence Images
  19. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming
  20. Prognostic Implications of HPV in Oropharyngeal Cancer
  21. Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3
  22. Molecular Basis of Gynecologic Diseases
  23. Human Papillomaviruses and Associated Malignancies
  24. Oncogenic activities of human papillomaviruses
  25. HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition
  26. Expression of a viral oncoprotein in normal human epithelial cells triggers an autophagy-related process: Is autophagy an “Achilles’ heel” of human cancers?
  27. Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation
  28. The human papillomavirus E7 oncoprotein
  29. Delocalization of the Microtubule Motor Dynein from Mitotic Spindles by the Human Papillomavirus E7 Oncoprotein Is Not Sufficient for Induction of Multipolar Mitoses
  30. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types
  31. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells
  32. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
  33. The Human Papillomavirus Type 8 E2 Gene Encodes a Transforming Activity Sufficient for Skin Tumor Formation in Transgenic Mice
  34. Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
  35. Viruses associated with human cancer
  36. Biochemical and Morphological Assessment of Normal and Pre-Cancerous Engineered Tissue Using Two-Photon Excited Autofluorescence
  37. Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells
  38. Diagnostic cellular organization features extracted from autofluorescence images
  39. Ring-Opening and Ring-Closing Reactions of a Shikimic Acid-Derived Substrate Leading to Diverse Small Molecules
  40. Human Papillomavirus E6 and E7 Oncogenes
  41. American Idol and NIH Grant Review—Redux
  42. Oncogenes
  43. Increased In Vitro Lifespan of Primary Human Keratinocytes Correlates with Decreased Migration
  44. Intrinsic fluorescence changes associated with apoptosis of human epithelial keratinocytes
  45. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding
  46. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
  47. Long-Term Maintenance of Human Keratinocytes In Vitro
  48. Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies
  49. Human Papillomavirus Infection and Centrosome Anomalies in Cervical Cancer
  50. Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuli
  51. Make WARTS, not cancer!
  52. The helix–loop–helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers
  53. Molecular pathways executing the “trophic sentinel” response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation
  54. Spectroscopic diagnosis and imaging of invisible pre-cancer
  55. TID1, a mammalian homologue of the drosophila tumor suppressor lethal(2) tumorous imaginal discs, regulates activation-induced cell death in Th2 cells
  56. Centrosomes, Genomic Instability, and Cervical Carcinogenesis
  57. Human papillomavirus immortalization and transformation functions
  58. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability
  59. Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein
  60. Aberrations in the MTS1 tumor suppressor locus in oral squamous cell carcinoma lines preferentially affect the INK4A gene and result in increased cdk6 activity
  61. Papillomaviruses
  62. The role of human papillomaviruses in human cancers
  63. Disruption of Oncogene/Tumor Suppressor Networks During Human Carcinogenesis
  64. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
  65. Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia
  66. The HPV E7 oncoprotein inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts
  67. Participation of Survivin in mitotic and apoptotic activities of normal and tumor‐derived cells*
  68. Centrosome abnormalities, genomic instability and carcinogenic progression
  69. Expression of the HPV E7 Oncoprotein Mimics but Does Not Evoke a p53-Dependent Cellular DNA Damage Response Pathway
  70. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state
  71. A Novel Human DnaJ Protein, hTid-1, a Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein
  72. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
  73. Destabilization of the RB Tumor Suppressor Protein and Stabilization of p53 Contribute to HPV Type 16 E7-Induced Apoptosis
  74. The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein
  75. Interactions of the human papillomavirus E7 protein with cell cycle regulators
  76. Dimerization of the Human Papillomavirus E7 Oncoproteinin Vivo
  77. The molecular biology of cervical cancer
  78. A Mutational Analysis of the Amino Terminal Domain of the Human Papillomavirus Type 16 E7 Oncoprotein
  79. Functions of Human Papillomavirus Proteins
  80. The human papillomavirus E7 protein as a transforming and transactivating factor
  81. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
  82. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
  83. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.
  84. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
  85. c-myc and pRB: Role in TGF- 1 Inhibition of Keratinocyte Proliferation
  86. Oncoproteins Encoded by the Cancer-associated Human Papillomaviruses Target the Products of the Retinoblastoma and p53 Tumor Suppressor Genes
  87. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains
  88. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
  89. Functional and Sequence Similarities Between HPV16 E7 and Adenovirus E1A
  90. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
  91. Peptide mapping of vertebrate and invertebrate metallothioneins
  92. Expression of the synthetic gene of an artificial DDT-binding polypeptide in Escherichia coli
  93. Isolation and Regulation of Expression of the Neurospora Crassa Copper Metallothionein Gene
  94. Luminescence Emission from the Cu(I)-Thiolate Complex in Metallothioneins
  95. Metal accumulation inAgaricus bisporus: Influence of Cd and Cu on growth and tyrosinase activity
  96. Viral carcinogenesis and genomic instability